EUVIMEDEUVIMED entdecken
Open Access

GZ17-6.02 interacts with bexarotene to kill mycosis fungoides cells

Michael R Booth, Laurence Booth, Jane L Roberts, Cameron West, Paul Dent

Oncotarget · 2024

DOI: 10.18632/oncotarget.28557 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncotarget, 2024. Verfasst von Michael R Booth und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, Virginia Commonwealth University, Richmond, VA 23298, USA. Hauptthemen laut MEDLINE: Antineoplastic Agents, Mycosis Fungoides, Skin Neoplasms. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsMycosis FungoidesSkin NeoplasmsHumansBexaroteneAMP-Activated Protein KinasesBeclin-1Receptors, Death Domain

Stichwörter der Autor:innen

ER stressGZ17-6.02autophagybexarotenevorinostat

Substanzen

BexaroteneAMP-Activated Protein KinasesBeclin-1Antineoplastic AgentsReceptors, Death Domain

Autor:innen und Institutionen

  • Department of Biochemistry and Molecular Biology, Virginia Commonwealth University, Richmond, VA 23298, USA.
  • Genzada Pharmaceuticals, Hutchinson, KS 67502, USA.

Zitieren

APA

Booth, M. R., Booth, L., Roberts, J. L., West, C., & Dent, P. (2024). GZ17-6.02 interacts with bexarotene to kill mycosis fungoides cells. Oncotarget. https://doi.org/10.18632/oncotarget.28557

Vancouver

Booth MR, Booth L, Roberts JL, West C, Dent P. GZ17-6.02 interacts with bexarotene to kill mycosis fungoides cells. Oncotarget. 2024. doi:10.18632/oncotarget.28557

BibTeX
@article{Booth2024,
  author = {Booth, Michael R and Booth, Laurence and Roberts, Jane L and West, Cameron and Dent, Paul},
  title = {GZ17-6.02 interacts with bexarotene to kill mycosis fungoides cells},
  journal = {Oncotarget},
  year = {2024},
  doi = {10.18632/oncotarget.28557}
}
Kostenlos starten →